首页> 外文期刊>Radiation Oncology Journal >The Measurements of Plasma Cytokines in Radiation-induced Pneumonitis in Lung Cancer Patients
【24h】

The Measurements of Plasma Cytokines in Radiation-induced Pneumonitis in Lung Cancer Patients

机译:肺癌患者放射性肺炎血浆细胞因子的测定

获取原文
获取外文期刊封面目录资料

摘要

PURPOSE: To investigate whether changes in plasma concentrations of transforming growth factor-beta1 (TGF-beta1), tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) could be used to identify the development of radiation-induced pneumonitis in the lung cancer patients. METHODS AND MATERIALS: Seventeen patients with lung cancer (11 NSCLC, 6 SCLC) were enrolled in a prospective study designed to evaluate clinical and molecular biologic correlation of radiation-induced pneumonitis. The study began in May 1998 and completed in July 1999. All patients were treated with radiotherapy with curative intent : 1.8 Gy per day, 5 fractions per week. Serial measurements of plasma TGF-beta1, TNF-alpha and IL-6 were obtained in all patients before, weekly during radiotherapy and at each follow-up visits after completion of treatment. These measurements were quantified using enzyme linked immunosorbent assay (ELISA). All patients were evaluated for signs and symptoms of pneumonitis at each follow-up visit after completion of radiotherapy. High resolution CT (HRCT) scans were obtained when signs and symptoms of pneumonitis were developed after completion of radiotherapy. RESULTS: Thirteen patients eventually developed signs and symptoms of clinical pneumonitis while four patients did not. TGF-beta1 levels were elevated in all 13 patients with pneumonitis, which showed characteristic pattern of elevation (38.45 ng/ml at pretreatment, 13.66 ng/ml during radiotherapy, then 60.63 ng/ml at 2-4 weeks after completion of radiotherapy). The levels of TNF-alpha and IL-6 were also elevated in the group of patients who developed pneumonitis but the pattern was not characteristic. CONCLUSIONS: Changes in plasma TGFbeta-1 levels before, during and after radiotherapy appears to be a useful means by which to identify patients at risk for the development of symptomatic pneumonitis. Other cytokines like TNF-alpha and IL-6 shows no meaningful changes in association with radiation pneumonitis.
机译:目的:调查是否血浆血浆中转化生长因子-beta1(TGF-beta1),肿瘤坏死因子-alpha(TNF-alpha)和白介素-6(IL-6)的浓度可用于确定放射线的发展。诱发肺癌患者的肺炎。方法和材料:17名肺癌患者(11例NSCLC,6例SCLC)被纳入一项前瞻性研究,旨在评估放射性肺炎的临床和分子生物学相关性。该研究始于1998年5月,并于1999年7月完成。所有患者均接受了根治性放疗:每天1.8 Gy,每周5次。所有患者在放疗前,放疗期间和治疗结束后的每次随访中均进行了血浆TGF-β1,TNF-α和IL-6的系列测定。使用酶联免疫吸附测定(ELISA)量化这些测量。放疗结束后的每次随访均评估所有患者的肺炎体征和症状。放疗完成后出现肺炎的体征和症状时,可获得高分辨率CT(HRCT)扫描。结果:13名患者最终出现了临床肺炎的体征和症状,而4名患者则没有。在所有13例肺炎患者中,TGF-β1水平均升高,显示出特征性的升高模式(治疗前38.45 ng / ml,放疗期间13.66 ng / ml,放疗后2-4周则60.63 ng / ml)。在发生肺炎的患者组中,TNF-α和IL-6的水平也升高,但是这种模式没有特征。结论:放疗之前,期间和之后血浆TGFbeta-1水平的变化似乎是鉴定有症状肺炎风险的患者的有用手段。其他细胞因子(如TNF-α和IL-6)与放射性肺炎无关,没有显示任何有意义的变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号